Eisai US

Eisai US

Pharmaceutical Manufacturing

Nutley, NJ 123,563 followers

Breaking through in the therapeutic areas of oncology and neurology. View our community guidelines: https://bit.ly/3dkY

Über uns

At Eisai Inc., human health care (hhc) is our goal. We give our first thought to patients and their families, and helping to increase the benefits health care provides. As the U.S. pharmaceutical subsidiary of Tokyo-based Eisai Co., Ltd., we have a passionate commitment to patient care that is the driving force behind our efforts to discover and develop innovative therapies to help address unmet medical needs. Eisai is a fully integrated pharmaceutical business that operates in two global business groups: oncology and neurology (dementia-related diseases and neurodegenerative diseases). Each group functions as an end-to-end global business with discovery, development, and marketing capabilities. Our U.S. headquarters, commercial and clinical development organizations are located in New Jersey; our discovery labs are in Massachusetts and Pennsylvania; and our global demand chain organization resides in Maryland and North Carolina. To learn more about Eisai Inc., please visit us at www.eisai.com/US. Comments and posts by users on this site are not created or controlled by Eisai Inc. and Eisai is not responsible for such content.

Website
http://us.eisai.com
Industrie
Pharmaceutical Manufacturing
Größe des Unternehmens
1.001-5.000 Mitarbeiter
Hauptsitz
Nutley, NJ
Typ
Öffentliches Unternehmen
Gegründet
1995
Spezialitäten
Neurology, Gastroenterology, Alzheimer's disease, Oncology, Epilepsy, Insomnia, Metastatic breast cancer, renal cell carcinoma, hepatocellular carcinoma, dementia, and endometrial cancer

Standorte

Employees at Eisai US

Aktualisierungen

Ähnliche Seiten

Jobs durchsuchen